1,355 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Lutronic recalled 7,490 units of the XERF EFFECTOR 60 electrosurgical unit on September 4, 2025. Manufacturing defects may lead to adverse events for patients. Devices manufactured between April 1, 2025, and August 20, 2025, are affected.
American Contract Systems recalled 32,433 medical convenience kits on September 4, 2025. The kits were re-gassed after a noncompliance during the Ethylene Oxide sterilization process. This raises concerns about their safety and effectiveness.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects a specific lot due to contamination with N-Nitroso Desmethyl Chlorpromazine. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Philips Medical Systems Nederland B.V. recalled two operating room tables on September 3, 2025. The recall affects models 722022 and 722033 due to potential system failures. The malfunction can inhibit motorized movements, posing a risk to patients and healthcare providers.
Zydus Lifesciences Ltd. recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects products with NDC 16714-050-01 due to high levels of a chemical impurity. Consumers should stop using the tablets immediately and contact healthcare providers.
Sun Pharmaceutical Industries recalled 1,870 kits of Technetium Tc 99m Mertiatide on September 3, 2025. The recall follows failed dissolution specifications for a key ingredient. The affected kits were distributed nationwide and pose a high risk to patients.
Philips Medical Systems recalled 286 Allura Xper FD10/10 imaging systems on September 3, 2025. The recall affects models 722011, 722027, and 722005 due to potential failure of internal components. This malfunction could inhibit motorized movements, posing risks to patient safety.
Philips Medical Systems Netherlands B.V. recalled three Allura Xper FD20/20 OR Tables on September 3, 2025. The recall addresses potential failures in internal components that could impede motorized functions. Users must stop using the device immediately and follow recall instructions.
Philips Medical Systems Nederland B.V. recalled 75 Allura Xper FD20/20 imaging systems on September 3, 2025. The recall affects systems due to internal component deterioration, which can hinder motorized movements. All users must stop using the device immediately and follow manufacturer instructions for safe handling.
Philips Medical Systems Nederland B.V. recalled 45 Allura Xper FD20/10 imaging systems on September 3, 2025. The systems may fail due to internal component deterioration, posing a high risk to users. Affected units include 11 in the U.S. and 34 internationally.
Philips Medical Systems Nederland B.V. recalled the Allura Xper FD20/15 OR Table on September 3, 2025. The recall affects one unit distributed worldwide, including the U.S. Systems may not perform as intended due to internal component deterioration.
Philips Medical Systems Netherlands B.V. recalled 1,117 X-ray imaging systems on September 3, 2025. The recall affects product codes 722010, 722026, and 722003 due to potential internal component deterioration. This issue may render motorized movements inoperable, posing a risk to patient care.
Zydus Lifesciences Ltd. recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects tablets containing N-Nitroso Desmethyl Chlorpromazine above safe limits. Consumers should stop using the product immediately and consult healthcare providers.
Philips Medical Systems Nederland B.V. recalled 98 radiology imaging systems on September 3, 2025. The recall stems from internal component deterioration that may hinder motorized movements. Patients and healthcare providers must stop using the devices immediately.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects 25 mg tablets due to high levels of N-Nitroso Desmethyl Chlorpromazine. Consumers must stop using the product immediately.
Philips Medical Systems Nederland B.V. recalled 46 imaging systems on September 3, 2025. Deterioration of internal components may lead to loss of motorized movements. Healthcare providers must stop using the systems immediately and follow recall instructions.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects 100-count bottles of 50 mg tablets due to excessive levels of N-Nitroso Desmethyl Chlorpromazine. Consumers should stop using the product immediately and contact health providers for guidance.
Zydus Lifesciences Ltd. recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects 10 mg tablets sold nationwide due to contamination with N-Nitroso Desmethyl Chlorpromazine. Consumers should stop using the product immediately and consult healthcare providers.
Philips Medical Systems Nederland B.V. recalled 174 OR tables on September 3, 2025. The recall affects models 722023, 722035, and 722015 due to potential failure of motorized movements. Users must stop using these devices immediately to prevent operational issues.
Philips Medical Systems Nederland B.V. recalled five Biplane OR Tables on September 3, 2025, due to potential failure of internal components. The recall affects models 722020 and 722025, distributed worldwide. Users must stop using the affected devices immediately to avoid operational issues.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride tablets on September 3, 2025. The recall affects tablets manufactured in India with high levels of a hazardous chemical. Consumers must stop using the product immediately and contact their healthcare provider.
Philips Medical Systems recalled 2,114 Allura Xper FD20 imaging systems on September 3, 2025. The systems may fail due to internal component deterioration, risking loss of motorized functionality. This recall affects 791 units in the U.S. and 1,323 globally.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The tablets exceed the acceptable limit for N-Nitroso Desmethyl Chlorpromazine. This recall affects the nationwide distribution in the USA.
Zydus Lifesciences recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects tablets with NDC 16714-051-01 due to N-Nitroso Desmethyl Chlorpromazine exceeding acceptable limits. Consumers should stop using the product immediately and consult healthcare providers.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.